Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

FDA grants early approval for Ultomiris for the treatment of adults with PNH

Dec. 24, 2018

Rivaroxaban thromboprophylaxis effective only during treatment period in cancer patients

Dec. 24, 2018

Novel anti-BMP6 targeted antibody reduces the need for EPO in anemia of chronic disease models

Dec. 21, 2018

Selatogrel significantly inhibits platelet aggregation in phase II studies

Dec. 19, 2018

China becomes first country to approve roxadustat

Dec. 18, 2018

FLT180a gene therapy safe in first two hemophilia B patients in clinical trial

Dec. 5, 2018

University of Pennsylvania divulges anti-PF-4 antibodies

Dec. 5, 2018

ASH 2018: Multiple studies give new insights into clotting cascade

Dec. 4, 2018

Bayer presents first phase I data for BAY-1093884 in patients with hemophilia

Dec. 3, 2018

Bayer initiates phase I II study of factor VIII gene transfer therapy with BAY-2599023

Dec. 3, 2018

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...